Hexarelin: The Most Potent GHRP and Its Cardioprotective Properties

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Hexarelin is the most potent GHRP for GH stimulation but also has unique direct cardioprotective effects independent of GH. It activates CD36 receptors on cardiac cells, reducing oxidative stress and protecting against ischemia-reperfusion injury. Hexarelin desensitizes with continuous use — cycling is essential.

Hexarelin: The Potent GHRP

Hexarelin is a synthetic hexapeptide GHRP that is the most potent member of the GHRP family for stimulating GH release. It activates the ghrelin receptor (GHSR-1a) more potently than GHRP-6, GHRP-2, or Ipamorelin. However, its most distinctive feature is its direct cardioprotective effects — effects that are independent of GH and mediated through a different receptor (CD36).

GH-Stimulating Effects

Hexarelin produces robust GH pulses when administered subcutaneously. Typical dosing: 100–200 mcg subcutaneously, 1–3 times daily. Like other GHRPs, it is most effective when combined with a GHRH peptide (CJC-1295 or Sermorelin) for synergistic GH release. Hexarelin desensitizes the ghrelin receptor with continuous use, making cycling essential: 4–6 weeks on, 2–4 weeks off.

Direct Cardioprotective Effects

Hexarelin's most unique property is its direct cardioprotective effects mediated through CD36 receptors on cardiac cells. These effects include: protection against ischemia-reperfusion injury (the damage that occurs when blood flow is restored to the heart after a blockage), reduction of oxidative stress in cardiac tissue, improvement of cardiac function in heart failure models, and anti-fibrotic effects in the heart. These cardioprotective effects occur at doses lower than those needed for GH stimulation and are independent of GH.

Who Might Benefit from Hexarelin?

Hexarelin may be particularly valuable for: individuals with cardiovascular risk factors or established heart disease (for its cardioprotective effects), those seeking the most potent GH stimulation available among GHRPs, and individuals who have not responded adequately to less potent GHRPs. Its desensitization profile makes it less suitable for long-term continuous use compared to Ipamorelin.

Side Effects and Considerations

Hexarelin shares the side effect profile of other GHRPs: cortisol elevation, prolactin increase, appetite stimulation, and water retention. Its potency means these side effects may be more pronounced than with Ipamorelin. Desensitization with continuous use is a significant limitation. Not recommended for individuals with active cancer due to the GH-stimulating effects.